Daclatasvir is a medication that's taken by mouth to treat hepatitis C infection. It's typically used once daily for 12 weeks. It has been discontinued by the manufacturer and is no longer available in the United States.
Chronic (long-term) hepatitis C infection genotype 1 or 3
Chronic hepatitis C infection
Chronic (long-term) hepatitis C genotype 1, 2, 3, 4, 5, or 6 infection in certain people age 3 years and older
Hepatitis C genotype 1 infection in people age 3 years and older who were previously treated with an NS5A inhibitor or an HCV protease inhibitor (not both)
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.